The red panda character with neuroblastoma helps young patients cope in this effort from Neon and United Therapeutics.

While the AI convo often revolves around generative AI, it’s the AI systems capable of powering the future of marketing that generate the most excitement. AI will replace sales reps as the center of ...

Newsom vetoed a bill that would have required insurers to cover, and pharmacists to dispense, 12 months of hormone therapy at one time to transgender patients and others.

Acadia Pharmaceuticals CEO Catherine Owen Adams breaks down the company’s recent rebrand, its expansion into rare disease marketing and how it’s using AI.

President Trump wants to lower GLP-1 prices; Novo Nordisk hires new corporate affairs lead; FDA announces priority drug review candidates.

The Food and Drug Administration (FDA) has sent out 12 more Untitled Letters to pharma companies amid its ongoing crackdown ...

Real Chemistry bought Spring & Bond, a New York-based digital media agency, on Wednesday morning. Financial terms were not ...

Industry analysts have suggested both Publicis Groupe and Havas could be potential acquirers of Dentsu’s international ...

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

Lina Polimeni was promoted to SVP and chief marketing office, consumer at Eli Lilly. Citrus Health Group, a 2025 MM+M Agency ...

Sora, OpenAI’s new social media app, has the power to transform medical marketing — here’s a peek into what it can do.

Underpinning the core of the campaign is the focus on making brain health accessible and enjoyable for older adults — whether through gaming or taking multivitamins.